Literature DB >> 18243822

Simultaneous determination of sulfamethoxazole and trimethoprim in biological fluids for high-throughput analysis: comparison of HPLC with ultraviolet and tandem mass spectrometric detection.

D C G Bedor1, T M Gonçalves, M L L Ferreira, C E M de Sousa, A L Menezes, E J Oliveira, D P de Santana.   

Abstract

The comparison of two methods based on online solid phase extraction-liquid chromatography with UV (SPE-LC-UV) or mass spectrometry detection (SPE-LC-MS/MS) for the simultaneous quantification of sulfamethoxazole (SMZ) and trimethoprim (TMP) is presented. The methods were validated and proved to be accurate. The analysis of standard samples for SMZ at concentrations of 0.5, 1.5, 25 and 50microg/mL demonstrated a relative standard deviation of less than 6% for both methods (n=18), while TMP samples at concentrations of 0.05, 0.15, 1.5 and 5.0microg/mL were analyzed with R.S.D. of less than 4% (n=18). The method with mass spectrometric detection was approximately six times more sensitive than the method with ultraviolet detection. The total run time for the SPE-LC-MS/MS was 2.5min per sample as opposed to 18.0min for the SPE-LC-UV method. The method with MS detection in comparison with UV detection proved to be more rugged and was successfully applied to pharmacokinetics studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18243822     DOI: 10.1016/j.jchromb.2007.12.027

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  Development and validation of an HPLC method for simultaneous determination of trimethoprim and sulfamethoxazole in human plasma.

Authors:  Esin Sayar; Selma Sahin; Semsettin Cevheroglu; A Atilla Hincal
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2010-09       Impact factor: 2.441

2.  Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spots.

Authors:  Daniel Gonzalez; Chiara Melloni; Brenda B Poindexter; Ram Yogev; Andrew M Atz; Janice E Sullivan; Susan R Mendley; Paula Delmore; Amy Delinsky; Kanecia Zimmerman; Andrew Lewandowski; Barrie Harper; Kenneth C Lewis; Daniel K Benjamin; Michael Cohen-Wolkowiez
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.695

3.  A Physiologically-Based Pharmacokinetic Model of Trimethoprim for MATE1, OCT1, OCT2, and CYP2C8 Drug-Drug-Gene Interaction Predictions.

Authors:  Denise Türk; Nina Hanke; Thorsten Lehr
Journal:  Pharmaceutics       Date:  2020-11-10       Impact factor: 6.321

4.  Pharmacokinetic comparison with different assays for simultaneous determination of cis-, trans-cefprozil diastereomers in human plasma.

Authors:  Seung-Hyun Jeong; Ji-Hun Jang; Hea-Young Cho; Yong-Bok Lee
Journal:  J Pharm Anal       Date:  2020-07-05

5.  Pharmacokinetic Comparison of Epinastine Using Developed Human Plasma Assays.

Authors:  Seung-Hyun Jeong; Ji-Hun Jang; Hea-Young Cho; Yong-Bok Lee
Journal:  Molecules       Date:  2020-01-03       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.